The Nomenclature of Tumours of the Nervous System

  • H. Hamperl
Conference paper
Part of the Acta Neurochirurgica / Supplementum book series (NEUROCHIRURGICA, volume 10)


It has always been clear that the histological types of tumour in man remain the same whatever the epoch and whatever the region. Definite differences affect at the most the incidence — and the name. However, in order to establish differences in the incidence of tumours, it is important to agree on generally recognized names, i. e. a nomenclature which permits a comparison and there-by definite establishment of regional and temporal differences. The International Union against Cancer (UIGC) has accordingly undertaken this task and already between the two world wars a Committee of experts was dedicated to this end. The work of the Committee was interrupted through the second world war and was again resumed in 1950. Since 1954 I have had the honour to be the Chairman of this Committee of the UICC which is composed of 8 scientists from all parts of the world. As a result of experience acquired in the numerous meetings of this body one became convinced that a common histological nomenclature of tumours of the brain could be of value *.


Carotid Body Giant Cell Tumour Glomus Tumour Carotid Body Tumour Olfactory Neuroblastoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. *.
    See: Unio Internationalis Contra Cancrum: Histological Nomenclature of Human Tumors. “Acta”, Vol. XIV, 1958. — Histologische Nomenklatur menschlicher Tumoren. Zsehr. Krebsforsch. 63 (1959), 75–98.Google Scholar
  2. *.
    See: Zülch, K. J., Biologie u. Pathologie d. Hirngesehwülste. Hdb. Neurochir., Bd. III, S. 1–702, Springer-Verlag, 1956.Google Scholar
  3. **.
    See: Henschen, F., Tumoren d. Zentralnervensystems u. seiner Hüllen. Hdb. spez. path. Anat. u. Histol. Bd. XIII, Teil 3, p. 438–1040, Springer, Berlin, 1955.Google Scholar
  4. *.
    For sarcomas arising from neurofibromas see V/1.Google Scholar
  5. 1.
    Copied from Pamphlet of the UICC.Google Scholar
  6. *.
    See: Rössle, R., Stufen der Malignität. Sitzungsber. d. Dtsch. Akademie d. Wissenschaften, Berlin, 1949. Akademie-Verlag. Berlin, 1950.Google Scholar
  7. *.
    Armed Forces Institute of Pathology, Washington 25, D. C., fascicles 35 and 37, Kernohan, J. W., and G. P. Sayre, Tumors of the central nervous system (1952), resp. fase. 29, Karsner, H. T., Tumors of the adrenal (1950).Google Scholar
  8. *.
    See: Kersting, G., Die Gewebszüchtimg menschlicher Hirngeschwülste, Springer-Verlag, Berlin-Göttingen-Heidelberg, 1961.CrossRefGoogle Scholar
  9. *.
    Müller: see Cardauns, H., Über ein malignes Plexuspapillom, Zbl. Neurochir. 17 (1957), 349–353.Google Scholar
  10. **.
    Van Hoytema, G. J., and W. E. Winckel, Zur Frage des primären Plexuskarzinoms, Zbl. Neurochir. 17 (1957), 353–363.Google Scholar
  11. *.
    See Zülch, K. J., Das Glioblastom, morphologisch und biologisch gesehen. Acta Neurochir. Suppl. VI (1959), 1–30.Google Scholar
  12. *.
    Fascicles of the Armed Forces Institute of Pathology, Washington 25, D. C.Google Scholar
  13. Problem Commission for Neurooncology Secretary: Prof. Dr. K. J. Zülch, Städt. Krankenanstalt, Ostmerheimer Straße 200, Köln, Deutschland.Google Scholar
  14. *.
    See: Cushing, H., and L. Eisenhardt, Meningiomas (their classification, regional behavior, life history and surgical end results). Thomas, Springfield and Baltimore, 1938.Google Scholar
  15. *.
    See: Cancer Seminar, Vol.II, Nr. 2 (1956).Google Scholar

Copyright information

© Springer-Verlag/Wien 1964

Authors and Affiliations

  • H. Hamperl

There are no affiliations available

Personalised recommendations